Stage-adapted treatment of HIV-associated Hodgkin lymphoma: results of a prospective multicenter study.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Journal of Clinical Oncology

• Publication date

  2012-11-20

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2012.41.8137PMID 23045592
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A retrospective multicenter analysis of elderly Hodgkin lymphoma: outcomes and prognostic factors in the modern era.

  2012cited by this paper
• Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.

  2012cited by this paper
• Dose-Escalation with BEACOPP Escalated Is Superior to ABVD In the Combined-Modality Treatment of Early Unfavorable Hodgkin Lymphoma: Final Analysis of the German Hodgkin Study Group (GHSG) HD14 Trial

  2010cited by this paper
• Sorafenib Treatment Reverses Depletion of Primitive Hematopoietic Stem Cells and Resolves FLT3-ITD Driven Myeloproliferative Disease In a Mouse Model.

  2010cited by this paper
• Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial.

  2010cited by this paper
• Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma.

  2010cited by this paper
• Frontline Therapy for Older Patients (pts) with Acute Myeloid Leukemia (AML): Clofarabine Plus Low-Dose Cytarabine Induction Followed by Prolonged Consolidation with Clofarabine Plus Low-Dose Cytarabine Alternating with Decitabine

  2010cited by this paper
• Hodgkin's Disease and HIV Infection (HD-HIV): Prognostic Factors In 596 Patients (pts) within the European Group for the Study of HIV and Tumours (GECAT)

  2010cited by this paper
• Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection.

  2009cited by this paper
• Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.

  2009cited by this paper
• Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation.

  2009cited by this paper
• Autologous stem-cell transplantation in patients with HIV-related lymphoma.

  2009cited by this paper
• VEBEP Regimen and Highly Active Antiretroviral Therapy (HAART) in Patients (pts) with HD and HIV Infection (HD-HIV): Final Results of the Italian Cooperative Group on AIDS and Tumors (GICAT) Study.

  2008cited by this paper
• Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma.

  2007cited by this paper
• Highly active antiretroviral therapy (HAART) improves survival in HIV-associated Hodgkin's disease: results of a multicenter study.

  2006cited by this paper
• Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS.

  2006cited by this paper
• VEBEP Regimen and Highly Active Antiretroviral Therapy (HAART) in Patients (pts) with HD and HIV Infection (HD-HIV).

  2005cited by this paper
• Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

  2005cited by this paper
• Hodgkin's lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin's Study Group.

  2005cited by this paper
• ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.

  2005cited by this paper
• Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus‐associated Hodgkin's disease

  2004cited by this paper
• Hodgkin's disease in HIV.

  2003cited by this paper
• Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy

  2003cited by this paper
• BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection.

  2003cited by this paper
• Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients.

  2003cited by this paper
• Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease.

  2003cited by this paper
• Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.

  2002cited by this paper
• Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

  2002cited by this paper
• A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

  1998cited by this paper
• 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

  1993cited by this paper

• Recognizing Lymphoma Risk in EBV- and HIV-Positive Patients: The Otorhinolaryngologist’s Perspective

  2026cites this paper
• Immune Deficiency/Dysregulation-Associated EBV-Positive Classic Hodgkin Lymphoma

  2025cites this paper
• Lymphoproliferations in People Living with HIV: Oncogenic Pathways, Diagnostic Challenges, and New Therapeutic Opportunities

  2025cites this paper
• A national, multicenter, retrospective study of human immunodeficiency virus infection-associated lymphoma in China

  2025cites this paper
• Human immunodeficiency virus-associated lymphomas: EHA-ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.

  2024cites this paper
• A comparison of clinical profile and treatment outcome of Hodgkin’s Lymphoma in Tanzania according to HIV status during the HAART era

  2024influential citation
• Immune deficiency/dysregulation -associated lymphoproliferative disorders. Revised classification and management.

  2024cites this paper
• Safety, efficacy, and affordability of ABVD for Hodgkin lymphoma in Malawi: a prospective cohort study

  2024cites this paper
• Clinical features in Hodgkin lymphoma patients living with human immunodeficiency virus: A meta-analysis in the antiretroviral therapy era

  2024cites this paper
• Stage‐adapted treatment of HIV‐associated Hodgkin lymphoma: Long‐term results of a prospective, multicenter study

  2024influential citation
• Human immunodeficiency virus‐associated Lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up

  2024cites this paper
• Clinical value of 18F-FDG PET/CT in the management of HIV-associated lymphoma

  2023cites this paper
• Optimising treatment of HIV-associated Hodgkin lymphoma.

  2023cites this paper
• Brentuximab vedotin with AVD for stage II-IV HIV-related Hodgkin lymphoma (AMC 085): phase 2 results from an open-label, single arm, multicentre phase 1/2 trial.

  2023cites this paper
• CD4+ T cell count in HIV/TB co-infection and co-occurrence with HL: Case report and literature review

  2023cites this paper
• New treatment strategies for HIV-positive cancer patients undergoing anticancer medical treatment: update of the literature.

  2023cites this paper
• Progress in the Treatment of HIV-Associated Lymphoma When Combined With the Antiretroviral Therapies

  2022cites this paper
• First Extensive Analysis of 18F-Labeled Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in a Large Cohort of Patients With HIV-Associated Hodgkin Lymphoma: Baseline Total Metabolic Tumor Volume Affects Prognosis

  2022cites this paper
• Impact of the HIV infection in Hodgkin lymphoma individuals: A protocol for systematic review and meta analysis

  2022cites this paper
• Clinical and Therapeutic Implications of Epstein–Barr Virus in HIV-Related Lymphomas

  2021cites this paper
• Outcomes of men with HIV and germ cell cancer: Results from an international collaborative study

  2021cites this paper
• HIV-associated lymphoma—advances in clinical management

  2021cites this paper
• Immunodeficiency-associated Hodgkin lymphoma

  2021cites this paper
• A retrospective study of distribution of HIV associated malignancies among inpatients from 2007 to 2020 in China

  2021cites this paper
• Hodgkin Lymphoma in People Living with HIV

  2021influential citation
• [Human immunodeficiency virus and lymphoma].

  2021cites this paper
• Hematological cancers in individuals infected by HIV.

  2021cites this paper
• Diagnostik und Therapie der HIV-assoziierten Lymphome: Update 2021

  2021cites this paper
• The Changing Landscape of Lymphoma Associated with HIV Infection

  2020cites this paper
• Prognostic factors affecting survival in children and adolescents with HIV and Hodgkin lymphoma in South Africa

  2020cites this paper
• LYMPHADENOPATHY IN THE HIV-POSITIVE PATIENT

  2020cites this paper
• HIV Lymphoma and Burkitts Lymphoma

  2020cites this paper
• Treatment management of haematological malignancies in people living with HIV.

  2020cites this paper
• The Management of HIV-Hodgkin Lymphoma

  2020cites this paper
• Hodgkin lymphoma

  2020cites this paper
• Aggressive Lymphomas

  2020influential citation
• Tumortherapie bei HIV-Infektion

  2020cites this paper
• Human Immunodeficiency Virus (HIV) Infection and Cancer

  2020cites this paper
• Optimizing treatment for HIV-associated lymphoma.

  2019cites this paper
• Hodgkin lymphoma in the modern combined antiretroviral therapy era

  2019cites this paper
• Hiv and Lymphoma: from Epidemiology to Clinical Management

  2019cites this paper
• HIV-triggered lymphoma

  2019cites this paper
• Epstein-Barr virus biomarkers have no prognostic value in HIV-related Hodgkin lymphoma in the modern cART era.

  2019cites this paper
• GESIDA/PETHEMA recommendations on the diagnosis and treatment of lymphomas in patients infected by the human immunodeficiency virus.

  2018cites this paper
• Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.

  2018cites this paper
• 18F-FDG-PET metabolic metrics and International Prognostic Score for risk assessment in HIV-infected patients with Hodgkin lymphoma

  2018cites this paper
• Utility of Epstein-Barr Virus Biomarkers in Human Immunodeficiency Virus-related Lymphomas in the Modern Combined Antiretroviral Therapy Era.

  2018cites this paper
• Hodgkin lymphoma at Groote Schuur Hospital, South Africa: the effect of HIV and bone marrow infiltration

  2018cites this paper
• Lymphomes associés à l’infection par le virus de l’immunodéficience humaine

  2018cites this paper
• Chapter 1 Human Immunodeficiency Virus ( HIV ) Infection and Cancer

  2018cites this paper
• Malignant lymphoma in the HIV‐positive patient

  2018cites this paper
• HIV Infection and Malignancy

  2018cites this paper
• Human Immunodeficiency Virus-Related Lymphomas

  2018cites this paper
• Head and Neck Lymphomas in HIV Patients: a Clinical Perspective

  2017cites this paper
• The role of F-18 FDG PET/CT in evaluating the impact of HIV infection on tumor burden and therapy outcome in patients with Hodgkin lymphoma

  2017cites this paper
• Human Immunodeficiency Virus (HIV) Infection and Cancer

  2017cites this paper
• HIV-Associated Malignant Lymphoma

  2017cites this paper
• Acquired immunodeficiency syndrome-related lymphoma

  2017cites this paper
• Malignancies in HIV-Infected and AIDS Patients.

  2017cites this paper
• Brentuximab vedotin with AVD shows safety, in the absence of strong CYP3A4 inhibitors, in newly diagnosed HIV-associated Hodgkin lymphoma

  2017cites this paper
• Drug Interactions in the Treatment of Malignancy in HIV-Infected Patients

  2017cites this paper
• HIV-infection has no prognostic impact on advanced-stage classical Hodgkin lymphoma.

  2017cites this paper
• Molecular Diagnostics for AIDS Lymphoma Diagnosis in South Africa and the Potential for Other Low- and Middle-Income Countries

  2017cites this paper
• Hodgkin lymphoma, HIV, and Epstein–Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study

  2017cites this paper
• Feasibility of interim positron emission tomography (PET)-adapted therapy in HIV-positive patients with advanced Hodgkin lymphoma (HL): a sub-analysis of SWOG S0816 Phase 2 trial

  2017influential citation
• MALIGNANT TUMORS IN HIV PATIENTS. LOCALIZATION, PREVENTION, AND TREATMENT. PART 2

  2017cites this paper
• Chemotherapy and Interactions with Combination Antiretroviral Therapy

  2016cites this paper
• Clinical management of HIV-associated hematologic malignancies

  2016cites this paper
• HIV Infection and Survival of Lymphoma Patients in the Era of Highly Active Antiretroviral Therapy

  2016cites this paper
• Human Immunodeficiency Virus as a Chronic Disease: Evaluation and Management of Nonacquired Immune Deficiency Syndrome-Defining Conditions

  2016cites this paper
• CHOP Chemotherapy for Aggressive Non-Hodgkin Lymphoma with and without HIV in the Antiretroviral Therapy Era in Malawi

  2016cites this paper
• Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group.

  2016cites this paper
• New treatment strategies for HIV-positive cancer patients undergoing antiblastic chemotherapy

  2016cites this paper
• CD4+ and CD8+ T-cell kinetics in aviremic HIV-infected patients developing Hodgkin or non-Hodgkin lymphoma

  2016cites this paper
• Management of human immunodeficiency virus-associated lymphomas

  2016cites this paper
• Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy

  2016influential citation
• Decision-making in the management of adult classical Hodgkin’s lymphoma: determining the optimal treatment

  2015influential citation
• Warnlampen, Diagnostik, Therapie

  2015cites this paper
• [In Process Citation].

  2015cites this paper
• Hodgkin lymphoma is as common as non‐Hodgkin lymphoma in HIV‐positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study

  2015cites this paper
• Spontaneous Regression of Refractory Diffuse Large B-Cell Lymphoma with Improvement in Immune Status with ART in a Patient with HIV: A Case Report and Literature Review

  2015cites this paper
• Clinical presentation and outcome of non-AIDS defining cancers, in HIV-infected patients in the ART-era: the Italian Cooperative Group on AIDS and tumors activity.

  2015cites this paper
• Risk assessment in the management of newly diagnosed classical Hodgkin lymphoma.

  2015cites this paper
• High Risk Features Contrast With Favorable Outcomes in HIV-associated Hodgkin Lymphoma in the Modern cART Era, ANRS CO16 LYMPHOVIR Cohort.

  2015cites this paper
• Cancer-Related Causes of Death among HIV-Infected Patients in France in 2010: Evolution since 2000

  2015cites this paper
• How I treat classical Hodgkin lymphoma in patients infected with human immunodeficiency virus.

  2015cites this paper
• Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges

  2014cites this paper
• Tivantinib: critical review with a focus on hepatocellular carcinoma

  2014cites this paper
• Managing HIV and Hodgkin Lymphoma in the Twenty-first century

  2014cites this paper
• Brentuximab vedotin in patients with relapsed HIV-related lymphoma.

  2014cites this paper
• The evolving scenario of non-AIDS-defining cancers: challenges and opportunities of care.

  2014cites this paper
• Diagnosis and management of lymphomas and other cancers in HIV-infected patients

  2014cites this paper
• Therapy of HIV-associated lymphoma—recommendations of the oncology working group of the German Study Group of Physicians in Private Practice Treating HIV-Infected Patients (DAGNÄ), in cooperation with the German AIDS Society (DAIG)

  2014cites this paper
• British HIV Association guidelines for HIV‐associated malignancies 2014

  2014cites this paper
• Hodgkin lymphoma in patients with HIV infection

  2014cites this paper
• Cancers in People with HIV and AIDS

  2014cites this paper
• Tivantinib in hepatocellular carcinoma

  2013cites this paper
• Lymphoma in Other Diseases

  2013cites this paper
• Implications of the shifting pathobiology of AIDS-related lymphoma.

  2013cites this paper
• Prevalence of HIV Infection among U.S. Hodgkin Lymphoma Cases

  2013cites this paper